Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly EPS (Basic) of -$0.99 for Q1 2026, down 27.27% year-over-year from -$1.36 in Q1 2025, and up 67.18% quarter-over-quarter from -$3.02 in Q4 2025.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported EPS (Basic) for 12 consecutive years, with -$0.99 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 27.27% year-over-year to -$0.99; the TTM figure through Mar 2026 stood at -$4.34 (down 70.09% YoY), while the FY2025 annual figure was -$5.02, down 11.92% from the prior year.
- EPS (Basic) advanced to -$0.99 in Q1 2026 per RNAC's latest filing, from -$3.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.7 in Q2 2022 and bottomed at -$38.04 in Q4 2023.
- Historically, EPS (Basic) has averaged -$3.12 across 5 years, with a median of -$1.41 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 4056.14% — and 2023, when it tumbled 3214.45%.
- Cartesian Therapeutics' EPS (Basic) stood at $1.22 in 2022, then sank by 3214.45% to -$38.04 in 2023, then jumped by 96.15% to -$1.46 in 2024, then slumped by 106.5% to -$3.02 in 2025, then jumped by 67.18% to -$0.99 in 2026.
- Business Quant data shows RNAC's EPS (Basic) at -$0.99 in Q1 2026, -$3.02 in Q4 2025, and -$0.95 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - | 0.47 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.47 |
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -2.98 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | -0.77 |
| Dec 31, 2024 | -1.41 |
| Sep 30, 2024 | -0.70 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | -2.25 |
| Dec 31, 2023 | -1.27 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.07 |
| Mar 31, 2023 | -0.13 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.08 |
| Dec 31, 2021 | 0.11 |
| Sep 30, 2021 | -0.16 |